A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients

<table>Progress of liver transplant recipients through the phases of the randomized study comparing a tacrolimus-based protocol with and without steroids. The rate of study completion was lower with TAC/DAC than with TAC/STR. Most commonly, patients in the TAC/DAC arm prematurely discontinued the study due to an adverse event. TAC: tacrolimus; DAC: daclizumab; STR: steroids; FAS: full analysis set; PAS: primary analysis set.</table>

Journal of Transplantation

fig1

Figure 1

Figure 1: A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients 